Company intelligence / Profile preview

TherapyX Inc.

Buffalo, New York, United Statestherapyxinc.com ↗

Ownership: Private
Development stage: Preclinical

Overview

The company has developed multiple preclinical candidates using their proprietary EXStaM platform. Their lead products have demonstrated efficacy in animal models of disease and are being prepared for clinical trials.

Therapeutic areas: GastroenterologyOncologyImmunologyInfectious Diseases
Modalities: Sustained-release microparticulate protein therapeuticsbiologicstherapeutic vaccinesprophylactic vaccinessmall molecule drugsinterleukins
Industry: Biotech

Drug pipeline

7 assets

PCX12

6 more assets in the full pipeline.

Request access →

Partnerships

IntravaccUniversity of Rochester

Beyond the preview

Go deeper on TherapyX Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TherapyX Inc..

Explore the full profile